1FUJITA T,YOKOTA S,SAWADA M,et al Effect of MKC-733,a 5-HT3 receptor partial agonist on bowel motility and symptoms in subjects with constipation:an exploratory study[J].J Clin Pharm & Ther.2005,30:611.
2COLEMAN NS,MARCIANI L,BLACKSHAW E,et al.Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans[J].Alim Pharm & Ther,2003,18:1039.
3IMANISHI N,LWAOKA K,KOSHIO H,et al.New thiazole derivatives as potent and selective 5-Hydroxytriptamine 3(5-HT3) receptor agonists for the treatment of constipation[J].Bioorg & Med Chem,2003,3(11):1493.
4DE SCHRYVER AM,ANDRIESSE GI,SAMSOM M,et al.The effects of the specific 5HT(4) receptor agonist,prucalopride,on colonic motility in healthy volunteers[J].Alim Pharm Ther,2002,2(16):603.
5MEYERS NL,PALMER RM,GEORGE A.Efficacy and safety of renzapride in patients with constipation-predominant IBS:A Phase Ⅱb study in the UK Primary Healthcare Setting[J].Gastroenterology,2004,126:A 640.
7POTET F,BOUYSSOU T,ESCANDE D,et al.Gastrointestinal pr-okinetic drugs have different affinity for the human cardiac human ethera-gogo K(+) channel[J].J Pharmacol Exp Ther,2001,299:1007.
8JI SW,PARK H,CHO J-S,et al.Investigation into the effects of mosapride on motility of guinea pig stomach,ileum,and colon[J].J Yonsei Med,2003,44:653.
二级参考文献31
1Fennerty MB. What are the treatment goals for helicobacter pylori infection? Gastroenterology 1997; 113 (Suppl): S120-125.
2Malfertheiner P, Megraud F, O;Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. European Helicobacter pylori Study Group (EHPSG). Current concepts in the management of helicobacter pylori infection-The Maastricht 2-2 000 Consensus report, Aliment Pharmacol Ther 2002; 16:167-180.
3Herrerias JM, Bujanda L, Pena D. Efficacy and cost study in Portugal and Spain of three different 7 day eradication regimens of Helicobacter pylori. Gastroenterology 1999; 116:A186.
4Spinzi GC, Bortoli A, Corbellini A. One Week therapy with omeprazole (PPY) or ranitidine bismuth citrate (RBC) and two antibiotics for the eradication of Helicobacter pylori in duodenal ulcer: a preliminary report. Gastroenterolgy 1998; 116:A294.
5Sung JY, Leung WK, Ling TK, Yung MY, Chan FK, Lee YT, Cheng AF, Chung SC. One week use of ranitidine bismuth citrate,amoxicillin and claritromycin for the treatment of Helicobacter pylori related duodenal ulcer. Aliment Pharmacol Ther 1998; 12:723-730.
6Susi D. The best treatment for Helicobacter pylori infection among for different 7 day triple therapies, Gut 1998; 43 (Suppl 2): A80.
7Peura DA. The report of the digestive health initiative international update conference on Helicobacter pylori. Gastroenterology 1997; 113:4-8.
9Pounder RE. New developments in H pylori eradication therapy. Scand J Gastroenterol 1997; 32 (suppl): 43-45.
10The European Helicobacter Pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41:8-13.
